Manufacture and quality control of CAMPATH-1 antibodies for clinical trials

1986, Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates, Br J Cancer, 54, 557, 10.1038/bjc.1986.209

1988, Guidelines on the production and quality control of monoclonal antibodies of murine origin intended for use in man, Trends Biotech, 6, G5

Hale, 1993, Small scale production of novel therapeutic products: A new challenge for the transfusion service?, [Editorial] Transfus Med, 3, 1, 10.1111/j.1365-3148.1993.tb00098.x

Hale, 2000, Isolation and purification of antibodies from tissueculture supernatant, 149

Hale, 1983, Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement, Blood, 62, 873, 10.1182/blood.V62.4.873.873

Hale, 1987, Isolation of low-frequency class-switch variants from rat hybrid myelomas, J Immunol Meth, 103, 59, 10.1016/0022-1759(87)90242-0

Page, 1991, High level expression of the humanized monoclonal antibody CAMPATH–1H in Chinese hamster ovary cells, Bio/Technology, 9, 64, 10.1038/nbt0191-64

Crowe, 1992, Humanized monoclonal antibody CAMPATH–1H: myeloma cell expression of genomic constructs, nucleotide sequences of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material, Clin Exp Immunol, 87, 105, 10.1111/j.1365-2249.1992.tb06421.x

Lifely, 1995, Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions, Glycobiology, 5, 813, 10.1093/glycob/5.8.813

Hale, 1988, Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H, Lancet, 2, 1394, 10.1016/S0140-6736(88)90588-0

Life Technologies Inc. Validation of virus inactivation in FBS by gamma irradiation. Life Technologies Report, 25 Oct. 1995.

Hale, 1994, Repeated cleaning of Protein A affinity column with sodium hydroxide, J Immunol Meth, 171, 15, 10.1016/0022-1759(94)90223-2

1995

Bhamra, 2000, Aseptic vial filling, 40, 313

Nacheva, 1987, Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia, Cancer Gen Cytogen, 28, 145, 10.1016/0165-4608(87)90364-5

Xia, 1991, Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone, Eur J. Immunol, 21, 1677, 10.1002/eji.1830210714

Hale, 1995, Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositolanchored glycoprotein, Immunotechnology, 1, 175, 10.1016/1380-2933(95)00017-8

Phillips, 2000, Measurement of antibody concentrations by haemagglutination, 40, 319

Bloom, 1989, Detection and reduction of Protein A contamination in immobilized Protein A purified monoclonal antibody preparations, J Immunol Meth, 117, 83, 10.1016/0022-1759(89)90121-X

1998, Normal immunoglobulin for intravenous use